Asim Farooq to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Asim Farooq has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.134
-
Management of belantamab mafodotin-associated corneal events in patients with relapsed or refractory multiple myeloma (RRMM). Blood Cancer J. 2021 05 26; 11(5):103.
Score: 0.134